Get started
Author

Mingfeng Yu

Targeting CDK6 in cancer: State of the art and new insights
2015 · Solomon Tadesse, Mingfeng Yu, et al. · Cell Cycle · 171
PDF
Cyclin-Dependent Kinase 8: A New Hope in Targeted Cancer Therapy?
2017 · Stephen Philip, Malika Kumarasiri, et al. · Journal of Medicinal Chemistry · 112
MAP Kinase-Interacting Kinases—Emerging Targets against Cancer
2014 · Sarah Diab, Malika Kumarasiri, et al. · Chemistry & Biology · 97
PDF
Discovery of 5‐(2‐(Phenylamino)pyrimidin‐4‐yl)thiazol‐2(3 H )‐one Derivatives as Potent Mnk2 Inhibitors: Synthesis, SAR Analysis and Biological Evaluation
2014 · Sarah Diab, Theodosia Teo, et al. · ChemMedChem · 85
CDK7 Inhibitors in Cancer Therapy: The Sweet Smell of Success?
2020 · Sarah Diab, Mingfeng Yu, et al. · Journal of Medicinal Chemistry · 82
Targeting CDK9: a promising therapeutic opportunity in prostate cancer
2016 · Muhammed H Rahaman, Malika Kumarasiri, et al. · Endocrine Related Cancer · 76
PDF
Highly Potent, Selective, and Orally Bioavailable 4-Thiazol- N -(pyridin-2-yl)pyrimidin-2-amine Cyclin-Dependent Kinases 4 and 6 Inhibitors as Anticancer Drug Candidates: Design, Synthesis, and Evaluation
2017 · Solomon Tadesse, Mingfeng Yu, et al. · Journal of Medicinal Chemistry · 75
Targeting CDK9 for treatment of colorectal cancer
2019 · Muhammed H. Rahaman, Frankie Lam, et al. · Molecular Oncology · 58
PDF
Targeting Pim Kinases for Cancer Treatment: Opportunities and Challenges
2015 · Bich Thuy Le, Malika Kumarasiri, et al. · Future Medicinal Chemistry · 50
Nontoxic Metal–Cyclam Complexes, a New Class of Compounds with Potency against Drug-Resistant Mycobacterium tuberculosis
2016 · Mingfeng Yu, Gayathri Nagalingam, et al. · Journal of Medicinal Chemistry · 49
Small-Molecule Inhibitors of Tankyrases as Prospective Therapeutics for Cancer
2022 · Mingfeng Yu, Yuchao Yang, et al. · Journal of Medicinal Chemistry · 45
Cdk5 in Oncology: Recent Advances and Future Prospects
2017 · Jimma Likisa Lenjisa, Solomon Tadesse, et al. · Future Medicinal Chemistry · 45
Pharmacologic co-inhibition of Mnks and mTORC1 synergistically suppresses proliferation and perturbs cell cycle progression in blast crisis-chronic myeloid leukemia cells
2014 · Theodosia Teo, Mingfeng Yu, et al. · Cancer Letters · 44
Discovery of (E)-3-((Styrylsulfonyl)methyl)pyridine and (E)-2-((Styrylsulfonyl)methyl)pyridine Derivatives as Anticancer Agents: Synthesis, Structure–Activity Relationships, and Biological Activities
2014 · Tiangong Lu, Aik Wye Goh, et al. · Journal of Medicinal Chemistry · 38
Discovery of 4-(dihydropyridinon-3-yl)amino-5-methylthieno[2,3-d]pyrimidine derivatives as potent Mnk inhibitors: synthesis, structure–activity relationship analysis and biological evaluation
2015 · Mingfeng Yu, Peng Li, et al. · European Journal of Medicinal Chemistry · 37
Efficient deprotection of F-BODIPY derivatives: removal of BF2 using Brønsted acids
2015 · Mingfeng Yu, Joseph K-H Wong, et al. · Beilstein Journal of Organic Chemistry · 37
PDF
Copper, Nickel, and Zinc Cyclam–Amino Acid and Cyclam–Peptide Complexes May Be Synthesized with “Click” Chemistry and Are Noncytotoxic
2011 · Mingfeng Yu, Jason R. Price, et al. · Inorganic Chemistry · 37
Clinical and CT Radiomics Nomogram for Preoperative Differentiation of Pulmonary Adenocarcinoma From Tuberculoma in Solitary Solid Nodule
2021 · Yaoyao Zhuo, Yi Zhan, et al. · Frontiers in Oncology · 36
Pharmacologic Inhibition of MNKs in Acute Myeloid Leukemia
2015 · Theodosia Teo, Frankie Lam, et al. · Molecular Pharmacology · 32
Discovery and pharmacological characterization of a novel series of highly selective inhibitors of cyclin‐dependent kinases 4 and 6 as anticancer agents
2017 · Solomon Tadesse, Laychiluh Bantie, et al. · British Journal of Pharmacology · 29
PDF
An integrated approach for discovery of highly potent and selective Mnk inhibitors: Screening, synthesis and SAR analysis
2015 · Theodosia Teo, Yuchao Yang, et al. · European Journal of Medicinal Chemistry · 29
Inhibition of Mnk enhances apoptotic activity of cytarabine in acute myeloid leukemia cells
2016 · Peng Li, Sarah Diab, et al. · Oncotarget · 28
Fabrication of metal-doped graphite phase carbon nitride-based membrane and its application
2024 · Wenbiao Zheng, Chengning Ye, et al. · Advanced Composites and Hybrid Materials · 27
PDF
A first-in-class CDK4 inhibitor demonstrates in vitro, ex-vivo and in vivo efficacy against ovarian cancer
2020 · Laychiluh Bantie, Solomon Tadesse, et al. · Gynecologic Oncology · 25
Dual Inhibition of Mnk2 and FLT3 for potential treatment of acute myeloid leukaemia
2017 · Sarah Diab, Ahmad M. Abdelaziz, et al. · European Journal of Medicinal Chemistry · 25
PDF
Works count: 79
Citation count: 1,719
H-index: 25
I10-index: 45
Year
Topic
Type